Chevron Corp vs Edwards Lifesciences Corporation Common Stock — how do they compare? Chevron Corp trades at $212.8 (market cap $414.98B), while Edwards Lifesciences Corporation Common Stock trades at $83.49 (market cap $48.56B). The key difference: Chevron Corp is far larger — about 8.5× Edwards Lifesciences Corporation Common Stock's market cap, and Chevron Corp pays a 3.37% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.
| CVX | EW | |
|---|---|---|
Market Cap | $414.98B | $48.56B |
Volume | 7,575,112 | 6,520,488 |
Sector | Energy | Health |
52-Week High | $217.73 | $95.18 |
52-Week Low | $146.72 | $72.65 |
Typical Hold Time | 101 Days | — |
Enterprise Value | $443.52B | $45.01B |
Dividend Yield | 3.37% | — |
Signals from Pluang's Aura AI — not financial advice
CVX trades at $205.19, down 1.17% on the day, with a neutral technical signal and bullish moving averages. The stock has consistently beaten earnings estimates in recent quarters, with Q2 2026 EPS of $6.06 exceeding the $5.55 forecast. Revenue declined to $184.43B in 2025, but a rebound to $208.7B is projected for 2026. Analyst consensus is a Buy with a $208.31 price target, and the company maintains a strong balance sheet with $6.79B in cash.
CVX presents a mixed outlook; earnings beats and a favorable analyst consensus support upside, but declining revenue and net income margins pose risks. High oil prices and strategic investments, like the $13.8B Argentina project, offer growth potential, yet geopolitical tensions and volatile energy markets remain headwinds for shareholders.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Chevron Corporation is an integrated energy company with operations in countries located around the world. The Company produces and transports crude oil and natural gas. Chevron also refines, markets, and distributes fuels, as well as is involved in chemical and mining operations, power generation, and energy services.
Read more on CVX →Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →